- ALS is a disease that stops the nerves for movement.
- It also makes breathing harder over time.
- Tofersen is a medicine for a rare form of ALS.
- The medicine can slow how fast ALS gets worse.
- Some people stay the same or get better.
- Improvements included better hand grip and breathing.
- Some people had headaches or body pain.
- Researchers are still studying the medicine and results.
Difficult words
- disease — A health problem that makes the body worse
- nerve — A body part that sends messages to musclesnerves
- breathe — To take air into the lungs and outbreathing
- medicine — A drug or treatment that helps a sick person
- rare — Not common; only a few cases
- improvement — A change that makes the condition betterImprovements
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you know anyone with a long illness?
- Have you ever had a headache or body pain?
- Do you take medicine when you are sick?
Related articles
Untreated Sleep Apnea Speeds Heart Aging and Raises Death Risk
A laboratory study using a long-term mouse model finds that untreated obstructive sleep apnea — recreated by repeated drops in oxygen during sleep — leads to faster cardiovascular aging and higher mortality. Researchers call for early screening and treatment.
Some low-cost glucometers read newborn glucose accurately
A Rice360 study tested commonly available point-of-care glucometers in the lab to see if low-cost models can measure newborn glucose safely. Several inexpensive meters gave reliable readings at neonatal ranges, offering options for low-resource hospitals.
New PET study links brain markers in Parkinson’s disease
Researchers used PET scans to compare two brain markers — dopamine transporters and synaptic density — in people with Parkinson’s and healthy volunteers. The study shows the usual link between markers breaks down in Parkinson’s.
New drug pair helps fight rifampicin-resistant tuberculosis
Scientists paired rifampicin with a probe called AAP-SO2 that binds bacterial RNA polymerase at a different site and slows transcription. The pair killed resistant mutants in culture and was especially effective in a rabbit model.
